3-aminobenzamide has been researched along with Blood Pressure, High in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Waldman, M | 1 |
| Nudelman, V | 1 |
| Shainberg, A | 1 |
| Abraham, NG | 1 |
| Kornwoski, R | 1 |
| Aravot, D | 1 |
| Arad, M | 1 |
| Hochhauser, E | 1 |
1 other study available for 3-aminobenzamide and Blood Pressure, High
| Article | Year |
|---|---|
PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1α axis.
Topics: Animals; Cells, Cultured; Diabetic Cardiomyopathies; Enzyme Inhibitors; Glucose; Heart; Hypertension | 2018 |